�Virginia Commonwealth University (VCU) researchers Kevin Ward, MD, Robert Diegelmann, PhD, and Gary Bowlin, PhD, this week received the Award for Excellence in recognition of their outstanding contributions to armed combat casualty upkeep from the US Army Medical Research and Materiel Command, Combat Casualty Care Research Program. The troika invented WoundStat�, a groundbreaking hemostatic agent for control of hemorrhage in high-pressure arterial wounds, which ar a vernacular combat combat injury. The award was given to the group "in recognition of their bleeding control research, and the resultant development of WoundStat, a product that will significantly increment survival of the armed combat wounded."
The award was given at the Advanced Technology Applications for Combat Casualty Care (ATACCC) 2008 Conference, and this is one of the few times the award has been tending to someone who was not a member of the military.
"I'm gratified, and I'm proud of the honor," said Dr. Ward. "Our team did great work in inventing WoundStat. It is rewarding knowing that your wreak can serve save lives of warfighters and other trauma victims, and it is great to be recognized as well."
After years of research, Ward, Diegelmann, and Bowlin developed a versatile and robust hemostatic material that is specifically suited to regale the staggeringly complex wounds of war under very demanding environmental conditions. WoundStat is both very absorbent material and disciple, which helps to quickly stop the bleeding while simultaneously facilitating clotting.
The patent-pending engineering behind WoundStat is the result of more than three days of medical research and development by VCURES. The university center not only conducts inquiry on lifesaving technologies, it plays a key role in training Special Operation Combat Medics in the U.S. military.
"We ar proud of these gentlemen - non only for their scientific and medical expertise, merely also for their commitment to our collective missionary work of forward combat casualty care. WoundStat is nowadays being deployed within the US military and has the potential to dramatically increase the survival rate of warfighters with stern, bleeding injuries," commented Devinder Bawa, CEO of TraumaCure, which manufactures and markets WoundStat. "Our partnership with VCU and these dedicated scientists has been staggeringly productive."
Four different medical research studies - including the one conducted by the U.S. Army's Institute for Surgical Research (ISR) - accept consistently proven that WoundStat is the most effective hemostat usable for high pressure arterial wounds.
About VCU and the VCU Medical Center Virginia Commonwealth University is the largest university in Virginia and ranks among the top side 100 universities in the country in sponsored research. Located on two business district campuses in Richmond, VCU enrolls more than 30,000 students in virtually 200 certificate and degree programs in the arts, sciences and humanities. Sixty-three of the programs ar unique in Virginia, many of them crossing the disciplines of VCU's 15 schools and one college. MCV Hospitals and the health sciences schools of Virginia Commonwealth University compile the VCU Medical Center, one of the nation's leading academic medical centers.
Virginia Commonwealth University
About TraumaCure TraumaCure, based in Bethesda, Maryland, supplies the most effective, reliable treatments for dangerous bleeding wounds. TraumaCure's hemostatic products help stabilize a wounded individual prior to receiving in advance medical handling. The company's products ar made in the U.S. and are proven to save lives and meliorate outcomes following traumatic hurt. TraumaCure is committed to providing the most trustworthy and groundbreaking hemostasis treatments for the military, emergency responders, and civilians.
TraumaCure
More info
